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Lack of TNFR p55 Results in Heightened Expression of IFN-g
and IL-17 during the Development of Reactive Arthritis
Ricardo J. Eliçabe,*,† Ethelina Cargnelutti,*,† Marı́a I. Serer,*,† Patricia W. Stege,‡,x
Susana R. Valdez,{,‖ Marta A. Toscano,#,** Gabriel A. Rabinovich,#,** and
Marı́a S. Di Genaro*,†
Reactive arthritis (ReA) is a type of arthritis originating from certain gastrointestinal or genitourinary infections. In previous
studies, we reported the development of progressive Yersinia enterocolitica-induced ReA in mice lacking TNFR p55; however, the
mechanisms underlying this effect are still uncertain. In this study, we investigated the impact of TNFR p55 deficiency in modu-
lating Ag-specific Th1 and Th17 responses during this arthritogenic process. We found more severe ReA in TNFRp552/2 mice
compared with their wild-type (WT) counterparts. This effect was accompanied by increased levels of Yersinia LPS in the joints of
knockout mice. Analysis of the local cytokine profile revealed greater amounts of IFN-g and IL-17 in arthritic joints of TNFRp552/2
mice compared with WT mice at day 21 postinfection. Moreover, altered IL-17 and IFN-g production was observed in mesenteric
and inguinal lymph nodes of Yersinia-infected TNFRp552/2 mice, as well as in spleen cells obtained from infected mice and
restimulated ex vivo with bacterial Ags. Increased levels of cytokine secretion were associated with a greater frequency of CD4+
IL-17+, CD4+IFN-g+, and IL-17+IFN-g+ cells in TNFRp552/2 mice compared with WT mice. Remarkably, Ab-mediated blockade
of IL-17 and/or IFN-g resulted in reduced joint histological scores in TNFRp552/2 mice. A mechanistic analysis revealed the in-
volvement of p40, a common subunit of heterodimeric IL-12 and IL-23, in the generation of augmented IFN-g and IL-17 produc-
tion under TNFR p55 deficiency. Taken together, these data indicate that, in the absence of TNFR p55 signaling, Th1 and Th17
effector cells may act in concert to sustain the inflammatory response in bacterial-induced arthritogenic processes. The Journal of
Immunology, 2010, 185: 4485–4495.
R
eactive arthritis (ReA), a group of arthritides also known as
spondyloarthropathies, represents a broad spectrum of in-
flammatory diseases that arise upon infection with certain
types of gastrointestinal or genitourinary pathogens (1). Infections
with Gram-negative bacteria, including Yersinia enterocolitica, are
associated with a risk for ReA in ∼1215% of patients (2). Because
the pathogenesis of ReA is incompletely understood, appropriate
treatments are not available (1).
TNF is a proinflammatory cytokine that signals via two cell
surface receptors, TNFR p75 (TNFR2; CD120b) and TNFR p55
(TNFR1; CD120a); the latter is implicated in most TNF effects (3,
4). This pleiotropic cytokine has been involved in the pathogenesis
of a variety of rheumatic and inflammatory diseases. However, TNF
has also been considered a critical cytokine capable of activating
macrophages during the protective host response against bacterial
infections, such as Y. enterocolitica (5). Interestingly, low TNF pro-
duction has been detected in sera of a high percentage of patients
with ReA (6, 7). Given the dual role of TNF as a pathogenic or host-
protective factor in autoimmune or microbial settings, the patho-
logical relevance of this cytokine in ReA remains unclear. In this
regard, we previously found that TNFR p55-driven immune-
protective mechanisms prevent the evolution to ReA upon oral in-
fection with Y. enterocolitica O:3, the most frequently associated
human arthritogenic serotype (8). Interestingly, TNFR p55-deficient
(TNFRp552/2) mice develop severe chronic arthritis compared with
their wild-type (WT) counterparts (8); however, the mechanisms
underlying these pathogenic effects remain uncertain.
Th17 cells have been recognized as the third effector T cell subset
in the portfolio of Th effector cells (9). Th17 cells play a pathogenic
role in several models of inflammatory and autoimmune disorders,
including rheumatoid arthritis, inflammatory bowel disease, psoria-
sis, uveitis, and multiple sclerosis (10, 11). Although mouse Th17
cells require TGF-b1 and IL-6 for their differentiation, human
Th17 cells can be generated in the presence of IL-1 and IL-6 (12).
Remarkably, expansion of human and mouse Th17 cells requires
IL-23, a heterodimeric cytokine consisting of a unique p19 subunit
linked to a common p40 chain (12). Of note, p40 can also be asso-
ciated with the p35 chain to generate IL-12, a critical cytokine re-
sponsible of promoting Th1 cell differentiation (13). Interestingly,
we found that Yersinia-infected p402/2 mice develop acute ReA
(14), in contrast to TNFRp552/2 mice, which show more severe and
chronic arthritis (8). However, IL-17 was also shown to act inde-
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pendently of TNF during the course of streptococcal cell wall-
induced arthritis (15). Furthermore, a recent study demonstrated in-
creased levels of IL-17, IL-6, TGF-b1, and IFN-g in synovial fluids
and sera of patients with ReA (16), and emerging data indicate an
essential role of the IL-23/IL-17 axis in the pathogenesis of spon-
dyloarthritis (17). Although Y. enterocolitica induces strong Th1
responses (18), the possibility that IFN-g and/or IL-17 might play
a role in Yersinia-induced ReA remains largely unexplored. In addi-
tion, it is still uncertain whether Th1- and Th17-differentiation path-
ways are regulated by TNF signaling during the course of bacterial-
induced inflammatory disease. In the current study, we aimed to
dissect the mechanisms underlying the increased severity of the
arthritogenic process in TNFRp552/2 mice following infection with
Y. enterocolitica. Given the essential role of IL-17 in the host mucosal
immune response (19), as well as the link frequently observed be-
tween gut inflammation and arthritis (20), we alsowished to examine
the in vivo cytokine profile observed in mucosal lymph nodes
compared with articular lymph nodes during the reactive arthrito-
genic process. Our data showed an augmented local inflammatory re-
sponse dominated by IL-17, IFN-g, IL-12p70, and IL-23 (p19/p40)
in TNFRp552/2mice comparedwithWTmice. Ab-mediated block-
ade of IL-17 and/or IFN-g resulted in significantly reduced histo-
pathological changes in the joints of these mice, suggesting that
IL-17 and IFN-g participate in the severe arthritogenic process
occurring in TNFRp552/2mice. Collectively, these data support an
in vivo regulatory role for TNFR p55 signaling in fine-tuning Th17
and Th1 programs during bacterial-induced ReA through modu-
lation of the common p40 subunit of IL-23 and IL-12.
Materials and Methods
Mice
TNFRp552/2 mice (C57BL/6) were kindly provided by the Max von
Pettenkofer Institute (Munich, Germany). C57BL/6 WT mice were pur-
chased from the Animal Facilities of the National University of La Plata,
La Plata, Argentina. Breeding colonies were established at the Animal
Facilities of the National University of San Luis. Mice were kept under
specific pathogen-free conditions in positive-pressure cabinets (EHRET,
Emmendingen, Germany) and provided with sterile food and water ad
libitum. Male mice (6-wk old) were used for the experiments. At least
three independent experiments were performed. Protocols were approved
by the Institutional Review Board of the Faculty of Medical Sciences,
National University of Cuyo. Animal work was approved by the Animal
Care and Use Committee of National University of San Luis.
Bacterial culture and infection
Strain MHC 700 Y. enterocoliticaO:3 (kindly provided by Dr. G. Kapperud,
Department of Bacteriology, Oslo, Norway) was used for infection. Bacteria
were cultured as described earlier (8). Mice were starved for 8 h and then
were infected orogastrically, with 1–5 3 108 yersiniae in 200 ml saline,
using a gastric tube. The number of inoculated bacteria was controlled by
plating serial dilutions of the inoculated suspension onMueller–Hinton agar
and counting the CFU following incubation at 26˚C for 48 h.
Assessment of arthritis
Mice were examined daily for visual appearance of arthritis in peripheral
joints, and the arthritis score was calculated until day 21 postinfection, as
described earlier (21). Clinical severity was classified for each paw: 0,
normal joint; 1, slight inflammation and redness; 2, severe erythematic and
swelling affecting the entire paw; and 3, deformed joint paw with ankylosis,
joint rigidity, and loss of function. Total score was based on the assessment
of all paws, with a maximum score of 12 per animal, as described (21).
Histopathological evaluation
Histopathological examination of the joints was carried out at day 21. After
routine fixation, decalcification, and paraffin embedding, 5-mm-thick sections
were cut and stained with H&E. Histopathological scoring was performed, as
described by Kyo et al. (22). Ankles from different groups of mice were
assigned histopathological scores of 0–5, where 0, normal; 1, minimal infiltra-
tion; 2, mild infiltration; 3, moderate infiltration; 4, marked infiltration; and 5,
severe infiltration. The same ankles were assigned a score for cartilage/bone
resorption, according to the following criteria: 0, normal; 1, minimal (small
areas of resorption); 2, mild (numerous areas of resorption); 3, moderate
(obvious resorption of trabecular and cortical bone without full-thickness
defects in the cortex; loss of some trabeculae); 4, marked (full-thickness
defects in the cortical bone and marked trabecular loss without distortion of
the remaining cortical surface profile); and 5, severe (full-thickness defects in
the cortical bone and marked trabecular bone loss, with distortion of the
remaining cortical surface profile). The total score was defined as the sum of
the scores for inflammation and for cartilage/bone destruction. Each slide was
scored by two independent observers, and the average score was recorded.
Micellar electrokinetic chromatography in joint homogenates
The presence of bacterial Ags was examined in homogenates of joints ob-
tained from Yersinia-infected TNFRp552/2mice and WTmice, as described
(22). The presence of LPS in these samples was determined by micellar
electrokinetic chromatography (MEKC). LPS from Y. enterocoliticaO:3 was
extracted by the hot phenol-water method, as described (23), and used as
positive control. For MEKC, we used a Beckman P/ACE MDQ instrument
(Beckman Coulter, Fullerton, CA) equipped with a diode array detector and
a data-handling system comprising an IBM personal computer and P/ACE
SystemMDQSoftware.The fused-silica capillaries (57 cm total length, 50 cm
effective length, 75 mm internal diameter, 375 mm OD) were obtained from
MicroSolvTechnology (Eatontown,NJ).Detectionwas performed at 197 nm,
the capillary temperaturewasmaintained at 18˚C, and thevoltagewas set at 25
kV. Samples were pressure-injected at the cathodic side at 0.5 c for 10 s. To
achieve high reproducibility of migration times, the capillary was washed
between analyses with sodiumhydroxide for 2min and then equilibratedwith
running buffer for 4 min. The background electrolyte used contained 20 mM
phosphate buffer (pH 8) and 10mMSDS. The electroendosmotic flowmarker
was prepared by diluting 1 ml acetone with the background electrolyte (1:1),
and sonication was applied for 5 min prior to injection.
In vitro cultures
At days 7, 14, and 21 postinfection, spleens were isolated, and erythrocytes
were lysed in 0.16 M NH4Cl (pH 7.2). Cells (2 3 10
6 cell/well) were
cultured in 24-well plates for 72 h at 37˚C in an atmosphere of 5% CO2 in
RPMI 1640 (HyClone, Logan, UT), supplemented with 10% FBS, 1 mM
pyruvate, 100 IU/ml penicillin, 100 mg/ml streptomycin, and 50 mmol/ml
2-ME in the presence or absence of 107 bacteria/ml heat-killed Yersinia
(HKY), as an Ag-specific stimulus (24), or ConA (5 mg/ml), as a mitogenic
stimulus. Culture supernatants were obtained and stored at 220˚C until
cytokine determination.
Cytokine determination by ELISA
Mouse IL-17, IFN-g, IL-6, IL-1b, TGF-b1, IL-12/IL-23 p40, IL-12p70, IL-
23 (p19/p40), and IL-10 were determined in the joint, mesenteric lymph node
(MLN), and inguinal lymph node (ILN) homogenates, prepared as described
previously (8), as well as in spleen cell culture supernatants using capture
ELISA kits (eBioscience, San Diego, CA), according to the manufacturer’s
instructions. The limit of detection for the above-mentioned cytokines was
4 pg/ml for IL-17, 0.7 pg/ml for IFN-g, 4 pg/ml for IL-6, 8 pg/ml for IL-1b,
60 pg/ml for TGF-b1, 2 pg/ml for IL-12/IL-23 p40, 30 pg/ml for IL-23
(p19/p40), and 30 pg/ml for IL-10. IL-12p70 was determined using the BD
OptEIA set.
Flow cytometry
Splenocytes were isolated from spleens of TNFRp552/2 mice and WT mice
21 d postinfection. Cells (13 106 cells/ml)were cultured for 72 h at 37˚C in an
atmosphere of 5% CO2 in RPMI 1640 (HyClone), supplemented with 10%
FBS and stimulatedwithHKY (63 107 bacterial/ml). Cells were restimulated
with PMA (50 ng/ml) and ionomycin (750 ng/ml) for 6 h in the presence of
GolgiPlug (BD 555029; BD Biosciences, San Jose, CA) for the last 5 h. After
washing, cells were stained with PE-Cy5–conjugated anti-CD4 (RM4-5; BD
Biosciences), fixed in 1% paraformaldehyde, and permeabilized using BD
FACS Permeabilizing solution (BD 340973; BD Biosciences), followed by
stainingwith PE-conjugated anti–IL-17 (eBio17B7) or FITC-conjugated anti–
IFN-g (XMGG1.2; both from eBioscience). Samples were analyzed on a
FACSAria flow cytometer (BD Biosciences). WinMDI 2.9 software was used
for data analysis. A gate was established to define CD4+ T cells.
Anti-cytokine–blocking experiments
IFN-g was blocked with a hamster anti-mouse IFN-g mAb (MAB4851),
and IL-17 was neutralized using a rat anti-mouse IL-17 mAb (MAB421;
both from R&D Systems, Minneapolis, MN). As control, the same doses of
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isotype-control Ab were injected. Briefly, TNFRp552/2 or WT mice were
treated in vivo with an anti–IFN-g mAb, an anti–IL-17 mAb, or a combi-
nation of both. Mice received anti-cytokine mAb (2.5 mg/kg) i.p. on days
16 and 18 postinfection. On day 21, ankle joints were obtained for his-
tological analysis.
Statistical analysis
Differences between the groups were tested for significance using the
Mann–Whitney U test or one-way ANOVA with the Dunnett multiple-
comparison test, as appropriate. A p value ,0.05 was considered statis-
tically significant. The results are expressed as the mean 6 SD.
Results
Impact of TNFR p55 deficiency on the development of chronic
ReA following Yersinia infection
Through activation of TNFR p55 signaling, TNF was demonstrated
to be a critical cytokine in the protective host response to Yersinia
(5, 24). Moreover, in recent studies, we found that TNFR p55 sig-
naling also plays a protective role against ReA induced by Y. en-
terocolitica O:3 (8). To further dissect the mechanisms involved
in this protective effect, we first examined disease progression in
TNFRp552/2mice comparedwithWTmice. TNFRp552/2mice that
did not succumb to Yersinia infection (survival: 60%) developed
a severe and progressive arthritis, with considerably increased clini-
cal score compared with WT mice, at day 14 (Fig. 1A). Moreover,
increased inflammatory swelling, disorganization of the synovial
membrane, proliferation of synovial lining cells with pannus for-
mation, and bone/cartilage degradation were clearly evident when
histopathological changeswere assessed in the joints ofTNFRp552/2
mice on day 21 after Yersinia infection (Fig. 1B). Joint inflammation
was observed until day 55, suggesting the development of chronic
arthritis in TNFR p55-deficient hosts (data not shown). Interestingly,
although WT mice showed a peak of arthritis on day 14, clinical
severity was markedly attenuated in comparison with TNFRp552/2
mice (Fig. 1A), and histopathological changes were considerably
reduced on day 21 postinfection (Fig. 1B). Taken together, these
results indicate a protective and tempering function of normal TNFR
p55 signaling in the development of Yersinia-induced chronic ReA.
FIGURE 1. TNFRp552/2 mice develop severe and progressive Yersinia-
induced ReA.WT (n = 6) and TNFRp552/2 (n = 10) age-matchedmalemice
were infected orally with Y. enterocolitica O:3 and monitored daily for
arthritis onset and clinical severity. A, The clinical score was calculated in
WT (n = 6) and surviving TNFRp552/2 mice (n = 6), as described in Ma-
terials and Methods, and represents the total paw swelling score for each
mouse. B, Histopathological examination of representative joints of WTand
TNFRp552/2 mice on day 21 postinfection (original magnification 3100).
Histological index was calculated at day 21 postinfection. Results (mean
score 6 SD) are representative of two or three independent experiments.
pp , 0.05. C, cartilage; JS, joint space; P, pannus; S, synovium.
FIGURE 2. TNFR p55 deficiency influences the abundance of Yersinia LPS
in the joints. A, MEKC was performed in joint homogenates of WT and
TNFRp552/2mice at day 14 postinfection, and chromatogramswere compared
with purified YersiniaLPS as positive control. A sharp peak in LPS (arrow) was
detected in homogenates of joints, but it was higher in TNFRp552/2 mice
compared with WT mice. Data are representative of three independent experi-
ments. B, Mean 6 SD of WT and TNFRp552/2 LPS abundance measured by
MEKC in three independent experiments. mA, microabsorbance. pp, 0.001.
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Influence of TNFR p55 deficiency in the control of bacterial
LPS in the joints of infected mice
Given the presence of outer membrane-specific Abs in sera from
TNFRp552/2 infected mice (8), we further examined whether an
increased bacterial Ag load in the joints of arthritic mice might
contribute to the increased severity of ReA in these mice. For this
purpose, we examined, by MEKC, the presence of LPS, the main
outer membrane component of the bacteria, in joint homogenates of
WT and TNFRp552/2 mice at days 14 and 21 postinfection. We
observed a sharp peak corresponding to purified Yersinia LPS in
joint homogenates of TNFRp552/2 and WT mice (Fig. 2), sug-
gesting that Yersinia LPS may trigger articular inflammation in
the early phase of arthritis in both groups of mice (day 14 post-
infection). However, LPS levels were significantly higher in
TNFRp552/2mice compared with WT mice (p, 0.001) (Fig. 2B),
suggesting increased bacterial Ags in mice devoid of TNFR p55
signaling. However, LPS was no longer detected at day 21 in
knockout or WT mice (data not shown). Thus, despite the presence
of a pronounced arthritogenic disease triggered by TNFR p55 de-
ficiency, bacterial Ags seem to be cleared from the joints of
TNFRp552/2 and WT mice during the ongoing infectious process.
These results suggest that immune-mediated mechanisms, acti-
vated early during bacterial invasion, may operate in concert to
trigger chronic ReA in TNFR p55-deficient mice.
Differential expression of proinflammatory cytokines in the
joints of Yersinia-infected TNFRp552/2 and WT mice
Compelling evidence indicates a critical role for IL-17 in sustaining
the inflammatory response in several models of arthritis (25–27).
This cytokine was shown to be fundamental in turning acute synovitis
into a chronic destructive arthritis (28, 29). In contrast, IFN-g is stron-
gly induced by Yersinia infection (18, 24) and is essential for initiating
joint inflammation in several arthritis models (30). Hence, we exam-
ined the relative abundance of IL-17 and IFN-g in joint homogenates
of TNFRp552/2 mice versus WT mice. Although we observed
a comparable induction of articular IL-17 in WT and TNFRp552/2
mice at days 7 and 14 postinfection, the amounts of IL-17 were sub-
stantially higher in TNFRp552/2 mice when analyzed 21 d after bac-
terial infection (p, 0.05) (Fig. 3A). Thus, disruption of the TNFRp55
pathway results in uncontrolled articular inflammation that persists at
day 21 and is accompanied by high amounts of IL-17 in the arthritic
joints. In addition, IFN-g was increased 7 d postinfection in WT and
knockout mice; however, this cytokine was upregulated in inflamed
joints of TNFRp552/2 mice but not in WT mice at days 14 and 21
postinfection (p , 0.05) (Fig. 3B). The increased arthritis severity,
togetherwith thehigher IFN-g levels and the lackofdifference in IL-17
at day 14 postinfection of TNFRp552/2 mice, suggests a dominant
contribution of IFN-g to joint inflammation during this time period.
Given the role of IL-6 and TGF-b1 in promoting Th17 cell dif-
ferentiation, we next examined the levels of these cytokines in the
joints of Yersinia-infected WT and TNFRp552/2 mice. We found
higher amounts of IL-6 in TNFRp552/2 mice compared with WT
mice, an effect that started as early as day 7 (p , 0.05), peaked at
day 14 (p, 0.05), and was sustained until day 21 (p , 0.05) after
bacterial infection (Fig. 4A). Furthermore, the concentration of
TGF-b1 was significantly higher in the joints of TNFRp55
2/2mice
at day 21 postinfection (p , 0.05) (Fig. 4B). Interestingly, lack
of TNFR p55 led to upregulation of TGF-b1, even in the absence
of bacterial Ags (Fig. 4B). Given the cooperative effects of IL-17
FIGURE 3. Lack of TNFRp55 augments IL-17 and IFN-g production in the
joints of mice with Yersinia-induced ReA. IL-17 (A) and IFN-g (B) in joint
homogenates of WT and TNFRp552/2 mice were prepared at different time
points postinfection andassayedbyELISA.Results are shownas themean6SD
of three independent experiments, with four or five mice per group. pp, 0.05.
FIGURE 4. Deficiency of TNFR p55 affects pro- and anti-inflammatory
cytokines in the joints of mice with Yersinia-induced ReA. Levels of IL-6 (A),
TGF-b1 (B), IL-1b (C), and IL-10 (D) in joint homogenates of WT and
TNFRp552/2 mice obtained at different time points postinfection. Results are
the mean 6 SD of three independent experiments, with four to five mice per
group. pp# 0.05.
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and IL-1b in sustaining joint inflammation (27), we next wished to
examine the concentrations of IL-1b in the joints of both groups of
mice. We found increased amounts of IL-1b in arthritic joints of
TNFRp552/2mice versus WT mice at days 7, 14, and 21 following
Yersinia infection (p , 0.05) (Fig. 4C). The increased amounts of
IL-6 (Fig. 4A) and IL-1b (Fig. 4C) in TNFRp552/2mice compared
with WT mice at all times analyzed suggested that these cytokines
may also be targets of regulation by TNFR p55 signaling. However,
in contrast to IFN-g and IL-17, the kinetics of IL-6 and IL-1b were
not in accordance with clinical expression of arthritis, suggest-
ing a secondary role of these cytokine in arthritis progression in
TNFRp552/2 mice. Interestingly, only when IL-6 and TGF-b1 in-
creased in TNFRp552/2 mice (day 21 postinfection) (Fig. 4B),
IL-17 increased in the joints of TNFRp552/2mice (Fig. 3A). Given
the immunoregulatory role of IL-10 at the peak and resolution of
inflammatory diseases (31), we further examined the regulation of
this cytokine in the joints of arthritic mice. Although the levels of
IL-10 increased significantly in WT mice at day 7 (p , 0.05), this
cytokine was substantially decreased in the joints of WT mice at
21 d postinfection, when joint inflammation was already resolved
(p, 0.05) (Fig. 4D). Collectively, these data indicate that different
pro- and anti-inflammatory cytokines are differentially regulated in
the joints of Yersinia-induced ReA in TNFRp552/2 mice and may
operate in concert to modulate the progression and severity of the
inflammatory disease.
Impact of TNFR p55 deficiency on systemic production of
IL-17 and IFN-g during Yersinia-induced ReA
To determine whether Th17- and Th1-type cytokine profiles pre-
dominate at the systemic level in TNFRp552/2 mice infected with
Yersinia, spleen cells from WT and TNFRp552/2 mice obtained 7,
14, and 21 d postinfection were stimulated ex vivo with HKY, and
supernatants were examined for Ag-specific IFN-g and IL-17
production (Fig. 5). Although discrete amounts of IFN-g and IL-17
were detected in spleen cell cultures of Yersinia-infected WT mice,
substantially higher concentrations of both cytokines were observed
inTNFRp552/2mice afterHKYstimulation (Fig. 5C, 5D).However,
no considerable changes were observed when spleen cells were ob-
tained from both groups of mice and stimulated ex vivo with ConA
(Fig. 5E, 5F). Interestingly, IL-17 reached concentrations signifi-
cantly higher only in supernatants of TNFRp552/2 spleen cells iso-
lated 14 d postinfection (p, 0.05; Fig. 5C). In contrast, the amounts
of IFN-gwere abundant in supernatants of TNFRp552/2 spleen cells
at all times tested (p, 0.05, p, 0.01, and p, 0.001 days 7, 14, and
21 postinfection versus WT spleen cells; Fig. 5D). These results
indicate augmented Ag-specific Th1 and Th17 responses in spleen
cells of TNFRp552/2 versus WT mice challenged with Yersinia.
Thus, in the absence of TNFR p55 signaling, Th17- and Th1-type
cytokines may play a role in driving the inflammatory response ob-
served in Yersinia-induced ReA, suggesting an immunoregulatory
role of the TNFR p55 pathway in attenuating Ag-specific Th1 and
Th17 responses in vivo. Remarkably, the time-course study of IL-17
expression correlated well with the clinical outcome of progressive
arthritis developed in TNFRp552/2 mice, suggesting a critical role
for IL-17 in Yersinia-induced chronic ReA.
Impact of TNFR p55 signaling in the cytokine profile of
mucosal and regional lymph nodes of Yersinia-infected
arthritic mice
Because mice developed joint inflammation following oral delivery
of Y. enterocolitica, we further studied the cytokine profile in mu-
cosal lymph nodes compared with joint regional lymph nodes.
FIGURE 5. Lack of TNFR p55 augments Ag-
specific IL-17 and IFN-g production by spleen cells
of mice with Yersinia-induced ReA. Spleen cells
from infected WT and TNFRp552/2 mice were
obtained at days 7, 14, and 21 postinfection and
cultured in the absence (A, B) or presence of HKY
(Ag-specific stimulation) (C, D) or ConA (polyclonal
activation) (E, F) for 3 d. Supernatants were col-
lected and assayed by ELISA for IL-17 (A, C, E) and
IFN-g (B, D, F). Values represent the mean6 SD of
two representative experiments with four mice per
group at each time point postinfection. pp # 0.05.
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For this purpose, we examined the amounts of IL-17, IFN-g, IL-6,
and TGF-b1 in tissue homogenates of MLNs and ILNs. Remark-
ably, IL-17 was significantly higher in MLNs of TNFRp552/2
mice versus WT mice at day 7; this effect was in line with that
found in ILNs (p , 0.001 and p , 0.01 compared with WT mice
in MLNs and ILNs, respectively; Fig. 6). Although similar levels of
IL-17 were detected in MLNs and ILNs in WT and TNFRp552/2
mice at day 14 postinfection, reduced levels of this cytokine were
observed in MLNs of TNFRp552/2 mice compared with WT mice
at day 21 postinfection (p , 0.05 versus WT mice), probably
reflecting migration of effector Th17 cells to target tissues. In
contrast, the differences in the levels of IL-17 in ILNs paralleled
those found in the joints of TNFRp552/2 and WT mice (p , 0.01;
Fig. 6B versus Fig. 3A). However, IL-17 expression in ILNs
showed a peak at day 14 postinfection and a tendency toward di-
minished expression at day 21 postinfection, in contrast to the ex-
pression profile in the joints. In addition, IFN-g was more abundant
in MLNs from TNFRp552/2 mice versus WT mice early post-
infection (day 7; p , 0.01; Fig. 6A). In contrast, an increase in
IFN-g could only be detected late postinfection (day 21) in ILNs of
mice devoid of TNFR p55 (p, 0.01). In keeping with the essential
role of IL-6 and TGF-b1 in promoting Th17 differentiation, these
cytokines showed a similar profile to that of IL-17. Hence, sub-
stantially higher amounts of IL-6 and TGF-b1 were detected in
MLNs from TNFRp552/2 mice compared with WT mice at day 7
postinfection (p , 0.01 versus MLNs from WT mice; Fig. 6A).
Likewise, we also detected a strong correlation among IL-17 and
the Th17-promoting cytokines IL-6 and TGF-b1 in ILNs, which
showed a higher concentration in ILNs of TNFRp552/2 mice at
day 7 (p , 0.05) or at day 21 (p , 0.01 and p , 0.05 for IL-6
and TGF-b1, respectively) postinfection (Fig. 6B). Taken together,
these data indicate a significant correlation among cytokines pro-
duced in mucosal-associated lymph nodes and those prevailing in
the joint regional lymph nodes of TNFRp552/2 mice early after
bacterial infection, supporting a link between the intestinal mucosa
and the local immune response operating in the arthritic joints.
Increased numbers of IFN-g– and IL-17–producing cells in
TNFRp552/2 mice
To determine the cell type responsible of producing IL-17 and
IFN-g during Yersinia infection, flow-cytometry analysis was per-
formed in splenic cells obtained from TNFRp552/2 and WT mice
on day 21 postinfection (Fig. 7A). A significantly higher frequency
of CD4+IL-17+ (p , 0.05), CD4+IFN-g+ (p , 0.05), and IL-17+
IFN-g+ (p , 0.01) cells were detected in TNFRp552/2 mice
compared with WT mice (Fig. 7B). These results support the
concept that Th1 and Th17 cells may contribute to sustain joint
inflammation during the arthritogenic process triggered by bac-
terial Ags. Moreover, the increased number of IL-17+IFN-g+CD4+
T cells in TNFRp552/2 mice suggested that these cytokines are
produced by double-positive T cells producing IL-17 and IFN-g.
Reduced joint inflammation and bone/cartilage erosion by
Ab-mediated neutralization of IFN-g and IL-17
To investigate the functional relevance of IFN-g and IL-17 in pro-
gressive Yersinia-induced ReA, blocking experiments were con-
ducted in TNFRp552/2 and WT mice by neutralizing IFN-g, IL-17,
or both cytokines in vivo. Remarkably, blockade of IFN-g, IL-17,
FIGURE 6. Lack of TNFR p55 influences
cytokine production in mucosal lymph nodes
and ILNs of mice with Yersinia-induced ReA.
Levels of IL-17, IFN-g, IL-6, and TGF-b1 in
homogenates of MLNs (A) and ILNs (B) from
WT and TNFRp552/2 mice at days 7, 14, and
21 postinfection. Values represent the mean 6
SD of four or five mice per group evaluated
each day postinfection. Results are representa-
tive of three experiments. pp # 0.05.
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or both cytokines successfully suppressed joint inflammation in an-
kle joints isolated on day 21 postinfection and markedly reduced
cartilage and bone erosion (Fig. 8). These data support the essential
roles of IL-17 and IFN-g in ReA progression in TNFRp552/2 mice.
TNFR p55 signaling regulates p40 expression in MLNs and ILNs
To identify possible mechanisms by which TNFR p55 deficiency
leads to increased Th17- and Th1-type cytokines, we next sought
to examine a potential convergent pathway that could be a com-
mon denominator to these divergent Th effector subsets. Hence,
we examined the expression levels of the p40 common chain that
is shared by the Th1-promoting cytokine IL-12 and the Th17-
promoting cytokine IL-23 (9, 13, 31). Expression of p40 was shown
to be critical in the pathogenesis of organ-specific autoimmune
disorders, particularly multiple sclerosis (10) and chronic inflamma-
tory arthritis (31, 32). Analysis of p40 expression in MLNs and ILNs
at day 21 postinfection revealed critical differences in TNFRp552/2
mice versus WT mice (Fig. 9). In fact, considerably higher levels
of p40 were detected in MLNs and ILNs of TNFRp552/2 mice
compared with WT mice (p , 0.05; Fig. 9). To dissect further the
role of IL-23 and IL-12 in these effects, IL-12(p70) and IL-23
(p19/p40) were also determined. We found increased levels of
IL-12(p70) and IL-23 (p19/p40) in ILNs of TNFRp552/2 mice
compared with WT mice (p , 0.05; Fig. 9B). The correlation of
these results with IFN-g and IL-17 production strongly suggests
that the TNFR p55-signaling pathway can suppress p40 protein
expression in mucosal and joint regional lymph nodes to coun-
teract the development of Th1 and Th17 responses. Thus, a
potential cross-talk among distinct proinflammatory pathways
could be proposed that controls the amplification and resolution of
pathogenic responses during Yersinia-induced ReA.
TNFR p55 signaling regulates IL-10 production in MLNs
and ILNs
IL-10, a potent anti-inflammatory cytokine, can antagonize Th1
and Th17 responses through inhibition of IFN-g and IL-17 (33, 34).
In addition, IL-10 plays a critical role in mucosal homeostasis, be-
cause IL-10 deficiency leads to spontaneous colitis due to aberrant
activation of dendritic cells (35). Thus, we compared the amounts of
IL-10 in MLNs and ILNs of TNFRp552/2 mice versus WT mice.
Notably, lack of TNFR p55 led to substantial differences in IL-10
kinetics and expression pattern (Fig. 10). IL-10 peaked earlier in
MLNs of TNFRp552/2 mice, as shown by its expression levels on
day 7 after Yersinia infection (p , 0.01 compared with MLNs of
WT mice; Fig. 10A). In contrast, augmented IL-10 production was
detected in MLNs of WTmice for only 21 d postinfection (p, 0.05
versus MLNs of TNFRp552/2mice; Fig. 10A). In contrast, the IL-10
peak was observed in ILNs from WT mice on day 14 postinfection,
coincident with the onset of the recovery of the synovial inflamma-
tory response (p, 0.05versus ILNsofTNFRp552/2mice; Fig. 10B).
In contrast, higher amounts of IL-10 were detected on days 7 and 21
postinfection in ILNs from TNFRp552/2 mice compared with WT
mice (p, 0.05 versus WTmice; Fig. 10B). Altogether, these results
indicate that an altered production of IL-10 in MLNs and ILNs may
contribute to the chronic progression of Yersinia-induced ReA in the
absence of TNFR p55 signaling. Given the distinct roles of IL-10
FIGURE 7. Increased IFN-g– and IL-17–producing cells in TNFRp552/2 mice. A, Splenic cells from TNFRp552/2 and WT mice were obtained 21
d after Yersinia infection. After ex vivo restimulation, cells were stained for cell surface CD4, intracellular IFN-g, and intracellular IL-17 and analyzed by
flow cytometry. Dot plots are representative of three mice per group. B, Data show mean 6 SD of the percentage of CD4+IFN-g+, CD4+IL-17+, or CD4+
IFN-g+IL-17+ cells (three independent experiments with n = 3 mice per group in each experiment). pp , 0.05.
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during immunoregulatory processes (35), this pleiotropic cytokine
may negatively or positively regulate the inflammatory response
based on its expression levels and the synergistic or additive actions
of other cytokines.
Discussion
TNF iswell-knownas amaster proinflammatory cytokine capable of
amplifying or modulating cytokine cascades in organ-specific auto-
immune diseases, including a broad range of rheumatic disorders.
TNF Abs and antagonists favor amelioration of clinical symptoms
and laboratory parameters by restoring homeostasis of innate and
adaptive immune cells (36). However, TNF is also a critical cytokine
in the protective host response against bacterial infection, includ-
ing Y. enterocolitica (5, 24), raising the question as to whether this
cytokine plays a pathogenic or protective role in bacterial-induced
ReA, a pathological entity that combines components of infection
and autoimmunity. We recently demonstrated that TNFR p55 sig-
naling confers protection against ReA induced by Y. enterocolitica
O:3 (8). In addition, unfavorable evolution has been reported
in patients with spondyloarthropathies under treatment with TNF
blockers (37). In the present work, we confirmed the protective role
of TNFR p55 signaling in Yersinia-induced ReA, demonstrating
that, in contrast to WT mice, TNFRp552/2 mice developed joint
inflammation with progression to a chronic arthritogenic process.
Because ReA is an aseptic synovitis (1, 2) and, no bacteria are
commonly detected in the joints of arthritic mice (8), we inves-
tigated the presence of bacterial Ags in the joints using MEKC,
a high-resolution separation technique widely used for trace anal-
ysis in biological samples (38). We detected Yersinia LPS at day 14
postinfection in the joints of WT and TNFRp552/2 mice, with
a higher concentration of this bacterial component in mice lacking
TNFR p55. This result is compatible with the impaired bacterial
clearance previously found in these mice (8). As a consequence,
bacterial Ags can trigger joint inflammation, as in other patholog-
ical conditions, such as Lyme arthritis (39). These results are in
keeping with our previous observations on the arthritogenic prop-
erties of Yersinia LPS (23) and the relevance of Yersinia outer
membrane Ags in triggering ReA in TNFRp552/2 mice (8). Im-
portantly, LPS could not be detected at day 21 postinfection, sug-
gesting that early stimulation with YersiniaAgs may be responsible
for triggering the immunopathogenic mechanisms implicated in the
chronicity of ReA (28).
The identification of the pathogenic Th17 subset capable of
inciting and perpetuating tissue injury via the release of IL-17
(9, 40) suggested the possibility that IL-17 may be involved in
chronic Yersinia-induced ReA observed in TNFRp552/2 mice. In
addition, Y. enterocolitica induces Th1 response in C57BL/6 mice
FIGURE 9. Lack of TNFR p55 increases the IL-
12/IL-23 p40 common subunit, IL-12p70 and IL-
23(p19/p40) during Yersinia-induced ReA. Levels
of p40, IL-12p70, and IL-23 (p19/p40) were as-
sessed in homogenates of MLNs (A) and ILNs (B)
from WT and TNFRp552/2 mice at day 21 post-
infection. Values represent the mean 6 SD of four
or five mice per group evaluated each day post-
infection. Results are representative of three
experiments. pp , 0.05.
FIGURE 8. Blockade of IFN-g and/or IL-17 reduces inflammation and
cartilage/bone erosion in ankle joints of TNFRp552/2 mice. On days 16 and
18 postinfection, TNFRp552/2 mice were treated with isotype-control Ab
(IgG1 or IgG2a) (A), anti–IFN-g (B), anti–IL-17 (C), or anti–IFN-g plus anti–
IL-17 (D) mAbs. E, Inflammatory cell infiltrates, bone/cartilage erosion, and
total histological scores were assessed at day 21 postinfection. Results are
the mean score 6 SD of at least three mice per group. pp , 0.05 versus
control group; one-way ANOVAwith the Dunnett multiple-comparison test.
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(18), and IFN-g regulates IL-17–producing T cells (41). To in-
vestigate the pathogenic role of Th17 and Th1 responses as poten-
tial mechanisms underlying the exuberant inflammatory responses
unleashed by TNFR p55 deficiency, we performed a comparative
kinetic analysis of the levels of IL-17 and IFN-g in the joints of WT
and TNFRp552/2mice. Remarkably, Yersinia infection triggered an
increase in IL-17 and IFN-g; however, IL-17 closely paralleled the
clinical score of arthritis at day 21 postinfection (a readout in-
dicating chronic arthritis). These results are in keeping with those
obtained by Abdollahi-Roodsaz et al. (28), who demonstrated IL-
17–dependent T cell-driven processes during the chronic phase of
arthritis in other experimental models. On the contrary, IFN-g was
higher at day 14 postinfection in mice lacking TNFR p55 signaling,
suggesting that Th1-type cytokines might contribute to the more
acute joint inflammation observed in TNFRp552/2 mice. Whether
these cytokines may arise as a result of the absence of protective
TNF signaling and whether they may synergize to compensate for
the lack of TNF functions remain to be ascertained. Notably, the
coexistence of Th17- and Th1-type cytokines in the absence of
TNFR p55 signaling contrasts with the widely recognized counter-
regulation of IL-17–producing cells by IFN-g (9); however, it was
recently reported that these pathogenic effector cells may indeed
coexist, particularly in the absence of other regulatory signals, such
as those triggered by TNF (42). In fact, the tendency toward reduced
levels of IFN-g, but higher levels of IL-17, on day 21 in the joints of
TNFRp552/2 mice may indicate a compensatory mechanism of
counterregulation of proinflammatory cytokines (43). The higher
Ag-specific IL-17 and IFN-g production detected in TNFRp552/2
micewas also confirmed in cultures of splenocytes. Interestingly, the
substantially higher amounts of IL-17 and IFN-g in TNFRp552/2
mice indicate a role of the TNF–TNFR p55 pathway as a negative
regulator of Th1- and Th17-type cytokines. These results are in line
with those recently reported in a model of collagen-induced arthritis
(42). Of note, our data support the concept that, under certain cir-
cumstances, proinflammatory cytokines may also display double-
edged effects and have regulatory attributes (44). Interestingly, we
also found a substantial increase in IL-6 and IL-1b expression in
TNFRp552/2 mice. However, the kinetics of these cytokine were
not in line with arthritis progression, suggesting a secondary role
for IL-6 and IL-1b in Yersinia-induced ReA in TNFRp552/2 mice.
The differentiation of naive CD4 T cells into specialized effector
subsets is controlled, in part, by cytokines present at sites of Ag
presentation (45). Although mouse Th17 cells require IL-6 and
TGF-b1 for their initial in vitro differentiation and IL-23 for their
expansion (46), the major cytokines that prime commitment of this
lineage in response to in vivo infection are poorly understood (45).
The concomitant increase in IL-17, as well as in IL-6 andTGF-b1, in
the joints of TNFRp552/2 mice confirmed the requirement of the
latter for sustained IL-17 secretion (46).
Because ReA is induced following oral infection, we also con-
ducted a comparative analysis of the cytokine profile in MLNs and
ILNs, as representative of mucosal and joint draining lymph nodes,
respectively. Interestingly, we found a strong correlation among
IL-17, IL-6, and TGF-b1 in MLNs and ILNs at early stages of
Yersinia infection (day 7) and during the arthritis onset (day 14),
supporting a link between gut and joint immune responses.
In accordance with Notley et al. (42), the coexistence of IL-17
and IFN-g challenges the assumption that differentiation of these
two subsets is mutually exclusive. In fact, more CD4+IL-17+ cells
and CD4+IFN-g+ cells was concurrently found in TNFRp552/2
mice, indicating that Th1 and Th17 cells might contribute to sustain
joint inflammation in these mice. Moreover, the higher number
of IL-17+IFN-g+CD4+ T cells in TNFRp552/2 mice indicates
that these cytokines are produced by double-positive (Th1/Th17)
T cells, suggesting a plasticity in T cell cytokine secretion and/or
a possible developmental association between the Th1 and Th17
phenotypes; this finding is supported by in vivo studies in other
mouse models (47). Importantly, Ab-mediated blocking experi-
ments revealed a considerable protection from joint damage when
IL-17, IFN-g, or both cytokines were neutralized in vivo. These
protective effects support a role for IL-17 and IFN-g in ReA pro-
gression in the absence of TNFR p55 signaling, as demonstrated for
other inflammatory diseases (48, 49).
Interestingly, recent studies reported defects in IFN-g regulation
in patients with other types of spondyloarthropathies, including an-
kylosing spondylitis (50). Thus, in a broader sense, our findings con-
tribute to the understanding of the pathogenesis of ReA, and they
have profound therapeutic implications, because specific blockade
of the TNF pathway in rheumatic disorders might lead to exacerba-
tion of pathogenic Th1 and Th17 responses (44). In contrast, recent
studies suggested that a cross-talk among distinct regulatory T cell
populations in the control of autoimmune inflammation (51). Ac-
cordingly, it was demonstrated that IL-6 and TGF-b1 upregulate
IL-10 (52), and TGF-b1 amplifies IL-10–producing regulatory-type
1 cells (53). Given the alterations observed in these cytokines in
our model, further experiments are warranted to elucidate the in-
fluence of TNFR p55 deficiency in regulatory T cell expansion
in chronic ReA.
In the search for potential mechanisms responsible for the aug-
mented Th17 and Th1 responses in TNFRp552/2mice, we assessed
the expression of p40, a common subunit of IL-12 and IL-23 het-
erodimeric cytokines, with respective Th1- and Th17-promoting
activity (13). Given the upregulation of Th1 and Th17 responses
in TNFRp552/2 mice, we hypothesized that p40 may act as a com-
mon mediator linking TNF signaling with Th1/Th17 responses.
FIGURE 10. Lack of TNFR p55 regulates IL-10 production during
Yersinia-induced ReA. IL-10 concentration was assessed in cellular ho-
mogenates of MLNs (A) and ILNs (B) from WT and TNFRp552/2 mice at
days 7, 14, and 21 postinfection. Values represent the mean 6 SD of four
or five mice per group evaluated each day postinfection. Results are rep-
resentative of three experiments. pp , 0.05.
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Importantly, we detected a substantial increase in p40 at day 21 in
MLNs and ILNs of TNFRp552/2 mice, and this effect correlated
with increased amounts of IL-12p70 and IL-23(p19/p40) in ILNs
of these mice. These data substantiate a role for the TNFR p55
pathway in silencing p40 production in vivo and provide a rational
explanation for the hyper-Th1 and hyper-Th17 responses observed
in TNFRp552/2 arthritic mice. These findings are consistent with
recent studies implying a functional cross-talk between TNF and
IL-12p40 in in vitro studies (54), collagen-induced arthritis (42),
experimental autoimmune encephalomyelitis (55), and streptococ-
cal cell wall-induced arthritis (32). In this regard, we observed
a self-limiting Yersinia-induced ReA in p402/2 mice (14). Taken
together, these data and the severe and progressive arthritis that
developed in TNFRp552/2 mice indicate a critical role for this
common cytokine subunit in modulating Th1 and Th17 responses
during the development of ReA.
In conclusion, our findings demonstrate that, in the absence of
TNF signaling, redundant pathways, particularly Th17 and Th1 ef-
fector cells, may act in concert to sustain inflammation in bacterial-
induced ReA, suggesting caution in the use of TNF blockers in
cases of acute or chronic ReA.
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